It surprises you that management requires payment for their services despite the stock price being low? That’s just reality.
I’m done buying because even if it goes lower it makes no difference in the bigger picture. My cost is now very low and I’m not worried at all. The stock is crazily undervalued. Nearly every early company in this sector and in biotech are in the same boat. Some will survive, some won’t. I believe this one will, and at this price that’s all I need to happen.
News 
Market Data 
Discover 
